Memorial Şişli Hospital
Memorial Şişli Hospital
Turkey, Istanbul
Dilek Necioglu Orken
37 years of experience
Clinic is certified :
Ocrevus (ocrelizumab) in Turkey typically costs from AUD $6,400 to AUD $11,200. Final pricing depends on the required dosage, clinic tier, and chosen city, with Istanbul and Ankara being the primary hubs. Patients from Australia save approximately 57% compared to local private costs, where the average price is AUD $20,800. Most Turkish packages include the medication, infusion monitoring, and initial neurologist consultations.
Bookimed Expert Insight: Australian patients find significant value at JCI-accredited facilities like Anadolu Medical Center. Its affiliation with Johns Hopkins Medicine provides reassurance of high clinical standards. Clinics such as Valued Med Hub and VM Medical Park Florya regularly treat Australians, providing familiar English-speaking support. Choosing university-affiliated hospitals often grants access to multidisciplinary teams, including neurology specialists like Dr. Baris Topcular, without the long waitlists common in Australia.
| Turkey | Thailand | South Korea | |
| Ocrevus (ocrelizumab) | ≈ AUD $6,400 | ≈ AUD $28,600 | ≈ AUD $12,200 |
Dr. Dilek Necioglu Orken is a neurologist at Memorial Sisli Hospital in Istanbul. She focuses on complex neurological conditions and patient management. Dr. Orken previously served as the Head of the Neurology Department at Demiroglu Science University. She also held the role of Education and Administrative Officer at Sisli Hamidiye Etfal Hospital.
Professor Mustafa Solak gained international expertise at the MD Anderson Cancer Center in the United States, focusing on advanced oncology protocols.
Professor Topcular completed specialist neurology training at the University of Basel in Switzerland, a global hub for multiple sclerosis research. He now leads neurological care at Istanbul Florence Nightingale Hospital.
The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.
With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.
The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.
Ocrevus (ocrelizumab) is approved and available in Turkey for treating relapsing and primary progressive multiple sclerosis. International patients can access this therapy through private JCI-accredited hospitals in Istanbul and Ankara. Specialist neurologists oversee administration via intravenous infusion. This typically requires recent MRI scans and a confirmed diagnosis from home.
Bookimed Expert Insight: Turkish private hospitals often maintain more flexible medication stock than public systems, which face tighter reimbursement rules. For Australians, the key advantage is the affiliation with US institutions like Johns Hopkins. This means clinical protocols for Ocrevus infusions in Istanbul mirror those used in leading neurology centres. Patients often benefit from shorter wait times for the initial consultation.
Patient Consensus: Visitors describe the medical experience in Turkey as highly professional and efficient. They appreciate the seamless coordination between airport transfers, hotel bookings, and clinic appointments.
Major medical centres in Turkey provide Ocrevus infusion therapy. These include Medicalpoint International Hospital in Izmir and Istanbul Florence Nightingale Hospital. These JCI-accredited facilities offer intravenous ocrelizumab for multiple sclerosis. The treatment is supervised by neurologists. These include Dr Ela Simay Zengin and Dr Baris Topcular.
Bookimed Expert Insight: Turkish neurology centres often operate within JCI-accredited smart hospitals. This infrastructure provides infusion suites with immediate access to intensive care teams if needed. Clinics like Medicalpoint International Hospital maintain steady medication stocks. These might be harder to source at smaller clinics.
Patient Consensus: Access in Turkey is reliable when confirmed through private infusion services. Patients suggest verifying stock and scheduling infusions well before travelling to Istanbul. The process is straightforward when handled by international patient departments.
International medical tourists can receive Ocrevus infusions in Turkey at JCI-accredited hospitals. Access requires an on-site consultation with a Turkish-licensed neurologist. The neurologist reviews the patient's medical history and MRI scans before issuing a local prescription. Treatment costs typically range from $4,500 to $7,800.
Bookimed Expert Insight: While Turkey serves over 1.6 million international patients annually, Ocrevus logistics are unique. Leading centres like Memorial Bahçelievler provide 3 Tesla MRI technology to verify disease activity before infusion. Patients should book at least 2 weeks in advance. This allows the pharmacy to secure the specific medication batch from the regulated supply chain.
Patient Consensus: Confirm hospital supply in Turkey well before arrival and carry all diagnostic documentation. Most people find travel manageable a few days post-infusion despite some initial tiredness.